- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04788732
Heart Rate Variability to Quantify General Anesthesia Depth
Heart Rate Variability as Tool for Quantification of General Anesthesia Depth in Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Anesthesia is a state of reversible unconsciousness induced by one or more pharmacological agents. The three main anesthesia components are analgesia (pain relief), amnesia (memory loss), and immobilization, including autonomic reflexes' inhibition for harmful stimuli.1 Drugs used to induce anesthesia, in general, have different effects on each of these three components mentioned above.
Anesthesia depth assessment ( DoA: from English, Depth of Anesthesia ) is essential for anesthetic practice. The DoA depends on two opposing factors: the amount of anesthetic agent administered to the patient and the stimuli produced during surgery, increasing the level of awareness, and the patient's nociception. The ideal level d the DoA involves the guaranteed unconsciousness and anti-nociception adequate during surgery without compromise the functions of vital organs. In other words, one of the main challenges for anesthetists is to identify the appropriate amount of anesthetic to be administered to avoid the unwanted effects of anesthetic shortages (leading, for example, to intraoperative awareness) or anesthetic overdose, which can cause severe problems during intra and postoperative periods. 2 Before using muscle relaxants, the appropriate level of DoA could be monitored by the absence of movements to painful stimuli; once, the surgical incision's lack of movements was a sure sign that the patient was not superficially anesthetized. However, with the muscle relaxants' adoption in the anesthetics protocols, other measures to ensure that anesthetic agents' concentrations were administered properly were necessary.
Becoming conscious during surgery is a major concern for patients and anesthesiologists. It is estimated that the incidence of consciousness during general anesthesia is low, around 0.04% to 0.3%. However, considering the high number of surgical interventions, accidental awareness during surgery represents thousands of cases worldwide. Therefore, despite being an old problem, awareness during anesthesia is still a very relevant issue in public health.
DoA inefficient may also lead to an imbalance nociception x anti-nociception intraoperatively, even without patient conscious pain. Nociceptive stimuli can substantially affect the physiological state, inducing, for example, tachycardia, hypertension, nausea, fainting, and, therefore, negatively influencing patients' postoperative period 1 Thus, careful and efficient monitoring of DoA is the key to minimizing both the possibility of accidental awareness in surgeries and the overdose of anesthetic agents. 3 However, despite the importance of monitoring d the DoA, it is not easy to quantify this parameter during general anesthesia, and several approaches have been proposed to accomplish this task.
Quantification of DoA:
The anesthetic depth could be identified by monitoring the sympathetic activity of the patient. However, many anesthetics substantially alter autonomic activity, both sympathetic and parasympathetic. The observation of autonomic responses such as sweating, tear formation, hypertension, tachycardia, and pupil dilation are also important indicators of adequate unconsciousness levels. However, these signals cannot guide the anesthetist, considering that the patient cannot react due to neuromuscular blockade. 3 On the other hand, some authors suggest monitoring the concentration of inspired and expired anesthetic gases as markers of DoA.4 However, to date, there is no standardized and universally accepted method for quantifying DoA, and the anesthesiologist's experience is still the most important and effective factor in determining DoA.
DoA's monitoring techniques have advanced considerably in recent years. The nature of changes in electroencephalographic patterns during the stages of anesthesia was studied in detail, opening up possibilities for monitoring DoA by identifying electroencephalogram (EEG) patterns with crucial clinical significance for anesthesia.5 The use of EEG devices made monitoring of DoA potentially easier and was recommended by NIH - Care Excellence.
Although the progress brought by EEG-based monitors to anesthetic practice is indisputable, they still have significant limitations: 1) the algorithms created to derive a single DoA index from the EEG are exclusive (owned by their creators) for each device; 2) The EEG obtained in these devices is limited, exclusively, to the activity of the frontal lobe, lacking the representation of deeper subcortical structures ; 3) EEG is recognized for being highly sensitive to a variety of sources of interference during monitoring; 4) it is high cost restricts the availability of such equipment. Several monitors have prices ranging from £ 4,687 to £ 10,285 for the initial purchase, followed by the acquisition of single-use sensors ranging from £ 0.56 to £ 14.08. (3) Also, recent studies have pointed to substantial divergences between the most common commercial displays at DoA, making the application of these electronic devices still controversial and not universally recommended. 4 Specific limitations to the use of BIS, such as the inconsistency of this index in some situations, have also been reported. 6 BIS's particular challenge involves the administration of ketamine, nitric oxide, and xenon, which do not produce the typical EEG patterns observed during general anesthesia with other anesthetic agents. Besides, as the BIS was created based on a database of volunteers under specific conditions, it must be revalidated whenever used with a new drug or even a unique patient population, whose characteristics differ from the original population database data.7
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Waynice N Paula-Garcia
- Phone Number: +5516981154121
- Email: wgarcia@fmrp.usp.br
Study Locations
-
-
Sao Paulo
-
Ribeirão Preto, Sao Paulo, Brazil, 14.048-900
- Recruiting
- Waynice N. Paula-Garcia
-
Contact:
- Waynice N Paula-Garcia
- Phone Number: +5516981154121
- Email: waynicegarcia@gmail.com
-
Contact:
- Phone Number: 2211 +551636021000
- Email: wgarcia@fmrp.usp.br
-
Principal Investigator:
- Waynice N Paula-garcia
-
Principal Investigator:
- Rubens Fazan Junior
-
Principal Investigator:
- Luis Vicente Garcia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- ASA patients (classification by the American Society of Anesthesiology) 1-3, of all ages, scheduled to undergo procedures under general anesthesia.
Exclusion Criteria:
- Patients with craniofacial deformities in which it is not possible to place the EEG sensors.
- Patients with severe eczema, allergy, or skin atopy.
- Patients with a history of severe autonomic dysfunction.
- Need of autonomic cardiac blockers during the intraoperative period.
- Absence of Consent.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1-Inhalation Anesthesia
patients in this group will be anesthetized only with an inhaled anesthetic ( Sevoflurane ).
|
the ECG and EEG will also be monitored during the entire period that the patients remain anesthetized with various anesthetics drugs and will later be used to compose the DoA score based on HRV.
|
2-Total Intravenous Anesthesia
the patients in this group will be anesthetized with only intravenous drugs such as benzodiazepícos (midazolam), opioids (alfentanil, fentanyl, sufentanil, remifentanil), hypnotics ( propofol and etomidate ), associated or not to relaxing neuromuscular (nondepolarizing/depolarizing), and adjuvant drugs such as dextrocetamina, dexmedetomidine, lidocaine, and magnesium sulfate.
|
the ECG and EEG will also be monitored during the entire period that the patients remain anesthetized with various anesthetics drugs and will later be used to compose the DoA score based on HRV.
|
3-Balanced anesthesia
the patients in this group will be anesthetized with blends of anesthetic inhaled (Sevoflurane) and intravenous drugs such as benzodiazepine (midazolam), opioids (alfentanil, fentanyl, sufentanil, remifentanil), hypnotics ( propofol and etomidate ), associated or not with neuromuscular relaxants (nonpolarizing/depolarizing) and adjuvant drugs such as dextrocetamine, dexmedetomidine, lidocaine, and magnesium sulfate.
|
the ECG and EEG will also be monitored during the entire period that the patients remain anesthetized with various anesthetics drugs and will later be used to compose the DoA score based on HRV.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To create a new Depth of Anesthesia (DoA) Score based on Heart Rate Variability indices
Time Frame: 12 months
|
Define a score capable of reflecting DoA, combining different indices derived from ECG, such as HRV.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of the differnet anesthetic drugs on the HRV indices (derived from ECG)
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the concentration and final consumption of anesthetic drugs throughout the anesthetic-surgical procedure.
|
12 months
|
Impact of the anesthesia adjuvant drugs on the HRV indices (derived from ECG)
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the concentration and final consumption of adjuvant drugs (for example: lidocaine, dexmedetomedine, magnesium sulfate) throughout the anesthetic-surgical procedure.
|
12 months
|
Time to wake up
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the time to wake up
|
12 months
|
Time spent in PACU
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the time spent in PACU
|
12 months
|
Aldrete score
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the Aldrete score
|
12 months
|
Incidence of nausea and vomiting
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the incidence of postoperative nausea and vomiting, .
|
12 months
|
Incidence of delirium
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the incidence of postoperative delirium
|
12 months
|
Incidence of intraoperative memory.
Time Frame: 12 months
|
Correlate HRV indices (derived from ECG) with the incidence of intraoperative memory.
|
12 months
|
Impact of frailty on the HRV indexes (derived from ECG)
Time Frame: 12 months
|
The impact of pre-anesthetic frailty (evaluated by the Clinical Frailty Scale) on ECG and EEG variables in the intraoperative period.
|
12 months
|
Impact of the basal cognitive status on the HRV indexes (derived from ECG)
Time Frame: 12 months
|
The impact of the basal cognitive status on ECG and EEG variables in the intraoperative period.
|
12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Guignard B. Monitoring analgesia. Best Pract Res Clin Anaesthesiol. 2006 Mar;20(1):161-80. doi: 10.1016/j.bpa.2005.09.002.
- Fahy BG, Chau DF. The Technology of Processed Electroencephalogram Monitoring Devices for Assessment of Depth of Anesthesia. Anesth Analg. 2018 Jan;126(1):111-117. doi: 10.1213/ANE.0000000000002331.
- Smith A. Literature review: Awareness of anaesthesia. J Perioper Pract. 2017 Sep;27(9):191-195. doi: 10.1177/175045891702700903.
- Merry AF, Cooper JB, Soyannwo O, Wilson IH, Eichhorn JH. International Standards for a Safe Practice of Anesthesia 2010. Can J Anaesth. 2010 Nov;57(11):1027-34. doi: 10.1007/s12630-010-9381-6. Epub 2010 Sep 21. No abstract available.
- Shander A, Lobel GP, Mathews DM. Brain Monitoring and the Depth of Anesthesia: Another Goldilocks Dilemma. Anesth Analg. 2018 Feb;126(2):705-709. doi: 10.1213/ANE.0000000000002383. No abstract available.
- Hajat Z, Ahmad N, Andrzejowski J. The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care. Anaesthesia. 2017 Jan;72 Suppl 1:38-47. doi: 10.1111/anae.13739.
- Kissin I. Depth of anesthesia and bispectral index monitoring. Anesth Analg. 2000 May;90(5):1114-7. doi: 10.1097/00000539-200005000-00021. No abstract available.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAAE: 33066620.1.0000.5440
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia Awareness
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedAnesthesia Awareness | Anesthesia; FunctionalTurkey
-
St George's, University of LondonUnknownAwareness, Anesthesia | Obstetric Anesthesia ProblemsUnited Kingdom
-
Brugmann University HospitalRecruitingAccidental Awareness During General AnesthesiaBelgium
-
Brno University HospitalMasaryk UniversityRecruiting
-
Dokuz Eylul UniversityCompletedAnesthesia AwarenessTurkey
-
Assiut UniversityCompletedAwareness, AnesthesiaEgypt
-
Rajiv Gandhi Cancer Institute & Research Center...Completed
-
KVG Medical College and HospitalUnknown
-
University Hospital Hradec KraloveRecruitingAnesthesia AwarenessCzechia
-
University of PennsylvaniaSuspended
Clinical Trials on ECG and EEG monitoring
-
University Hospital, GrenobleLaboratoire de Psychologie et NeuroCognitionCompletedAutism Spectrum DisorderFrance
-
The Leeds Teaching Hospitals NHS TrustLeeds and York Partnership NHS Foundation TrustUnknownCardiovascular Diseases | Dementia | Mental Health DisorderUnited Kingdom
-
Cara Medical LtdRecruitingTranscatheter Aortic Valve ReplacementUnited States
-
Charite University, Berlin, GermanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedImpact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke (MonDAFIS)Stroke | Atrial FibrillationGermany
-
Brainmarc Ltd.Unknown
-
Centre de Recherche de l'Institut Universitaire...Active, not recruitingAortic Valve Stenosis | ArrythmiaCanada
-
Tel-Aviv Sourasky Medical CenterTerminated
-
Ruhr University of BochumUnknownPropofol Dosage | Electroencephalography | Gender IdentityGermany
-
Ruhr University of BochumUnknownPropofol | Electroencephalography | Gender IdentityGermany
-
Cara Medical LtdRecruitingTranscatheter Aortic Valve ReplacementSpain, Canada, Italy